We are calling for the development of a point-of-care TB test and working to increase access to treatment for drug resistant TB by supporting the introduction of promising new medicines and tackling supply problems of older drugs.

22. March 2018.

Governments still not doing enough to scale up access to newer TB drugs

As of February 2018, only 16,069 people worldwide had received bedaquiline and only 1,247 people had received delamanid.

Read more

Photo by Alessandro Penso

Tuberculosis: The Issues

Cambodia © Sean Brokenshire/MSF

Learn about the issues MSF & others confront in the diagnosis and treatment of tuberculosis.

» Read more

Featured multimedia

XDR-TB patient successfully completes treatment
Late 2013, Elizabeth started treatment for multidrug-resistant tuberculosis (MDR-TB) at MSF’s Green House Clinic in Nairobi...

Tags: tuberculosis, XDR-TB, bedaquiline

↑ To top